核心 发表于 2025-3-25 06:54:32

Submitted on: 08 August 2023.
Revised on: 06 September 2023.
Accepted on: 23 September 2023.
Translational Cancer Research

提名 发表于 2025-3-25 09:58:15

Submitted on: 27 October 2019.
Revised on: 03 December 2019.
Accepted on: 30 December 2019.
Translational Cancer Research

易受骗 发表于 2025-3-25 13:41:36

Submitted on: 24 November 2009.
Revised on: 02 January 2010.
Accepted on: 25 January 2010.
Translational Cancer Research---AME PUBLISHING COMPANY

collateral 发表于 2025-3-25 18:54:00

Submitted on: 31 May 2013.
Revised on: 02 July 2013.
Accepted on: 09 July 2013.
Translational Cancer Research

准则 发表于 2025-3-25 21:23:00

http://reply.papertrans.cn/3/298/29781/29781-25.png

Highbrow 发表于 2025-3-26 02:05:24

http://reply.papertrans.cn/3/298/29781/29781-26.png

giggle 发表于 2025-3-26 05:10:51

http://reply.papertrans.cn/3/298/29781/29781-27.png

欢腾 发表于 2025-3-26 10:39:33

http://reply.papertrans.cn/3/298/29781/29781-28.png

armistice 发表于 2025-3-26 16:18:04

Submitted on: 04 December 2019.
Revised on: 14 December 2019.
Accepted on: 22 December 2019.
Translational Cancer Research

legacy 发表于 2025-3-26 17:49:29

Submitted on: 16 October 2008.
Revised on: 02 November 2008.
Accepted on: 22 November 2008.
Translational Cancer Research
页: 1 2 [3] 4
查看完整版本: SCIE期刊Translational Cancer Research 2024/2025影响因子:1.514 (TRANSL CANCER RES) (2218-676X). (ONCOLOGY)(肿瘤学)Science Citatio